Related Experiment Video

Updated: Jul 11, 2026

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

Improving the efficacy of antibody-based cancer therapies

P Carter1

  • 1Immunex, Seattle, Washington 98101, USA. carterp@immunex.com

Nature Reviews. Cancer
|March 22, 2002
PubMed

Insights

Monoclonal antibodies are a rapidly growing pharmaceutical class for treating diseases like cancer. Innovative strategies are being developed to enhance the effectiveness of these antibody therapies in cancer treatment.

Area of Science:

  • Immunology
  • Pharmacology
  • Oncology

Background:

  • Monoclonal antibodies (mAbs) represent a significant advancement in modern medicine, particularly in oncology.
  • Over the past 25 years, mAbs have emerged as a major class of therapeutics for various human diseases.

Purpose of the Study:

  • To review the current landscape and future directions of monoclonal antibody therapies in cancer treatment.
  • To highlight innovative approaches aimed at improving the efficacy of antibody-based cancer therapies.

Main Methods:

  • Literature review of monoclonal antibody applications in cancer therapy.
  • Analysis of emerging trends and novel strategies in antibody development and utilization.

Main Results:

  • Monoclonal antibodies are a rapidly expanding pharmaceutical class with broad applications in treating human diseases, including cancer.
  • Despite not yet achieving a universal cure for cancer, significant progress has been made.

Conclusions:

  • Monoclonal antibody therapy remains a cornerstone in cancer treatment, with ongoing innovation promising improved patient outcomes.
  • Further research and development in antibody-based approaches are crucial for advancing cancer care and achieving therapeutic breakthroughs.

More Related Videos

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research08:53

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

Published on: September 16, 2019

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...